Insmed INSM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$1.18B-16.8% | -$1.28B-39.7% | -$1.18B-37.0% | -$1.03B-28.9% | -$1.01B-35.7% | ||
| $11.5M+83.8% | $10.45M+75.3% | $8.3M+39.4% | $7.3M+21.9% | $6.26M+6.6% | ||
| $159.2M+38.9% | $152.71M+57.7% | $140.23M+55.3% | $134.34M+58.6% | $114.65M+43.7% | ||
| $5.78M-15.7% | $6.22M-9.7% | $6.59M-4.4% | $6.73M-7.1% | $6.86M-7.9% | ||
| $131.86M+1,153% | $88.31M+583% | $22.82M+304% | $12.63M+17.5% | $10.53M+29.2% | ||
| $32.38M+85.4% | $31.52M+84.9% | $21.88M+13.0% | $14.69M+5.8% | $17.47M+34.1% | ||
| $127.69M+727% | $100.07M+124% | $50.86M+102% | $6.02M-65.9% | $15.45M+285% | ||
| $14.65M— | $2.12M— | -$12.37M— | —— | —— | ||
| -$3.32M+58.3% | -$4.99M+58.2% | -$8.66M+32.0% | -$8.18M+35.0% | -$7.97M+49.3% | ||
| $20.77M+2.6% | $20.68M+3.1% | $20.41M+3.0% | $20.54M-16.9% | $20.25M-3.8% | ||
| $6.82M+35.0% | $6M+18.8% | $5.33M+5.4% | $5.05M0.0% | $5.05M0.0% | ||
| $186.73M— | $251.99M— | —— | —— | —— | ||
| -$895.66M-17.6% | -$935.01M-36.7% | -$883.4M-42.8% | -$844.55M-47.1% | -$761.94M-32.7% | ||
| $25.97M-4.9% | $32.56M+48.5% | $22.74M+31.4% | $24.02M+45.8% | $27.31M+87.5% | ||
| $1.65B— | $2.09B— | $2.37B— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $1.19B+44.3% | $1.11B+614% | ||
| $3.05M+13.3% | $2.96M+13.4% | $2.87M— | $2.78M— | $2.7M— | ||
| $954.59M-30.2% | $954.07M-28.9% | $1.08B-17.3% | $1.44B+58.8% | $1.37B+695% | ||
| —— | —— | —— | $2.23M— | $541K— | ||
| —— | —— | -$126.69M-394% | $37.53M-94.1% | -$192.48M+48.4% | ||
| $55.35M+21.7% | $55.35M+36.4% | $57.08M+69.6% | $50.26M+52.4% | $45.48M+40.3% | ||
| $4.91M+41.5% | $4.14M+65.7% | $4.28M+83.9% | $3.79M+75.9% | $3.47M+60.6% | ||
| $5.78M-15.7% | $6.22M-9.7% | $6.59M-4.4% | $6.73M-7.1% | $6.86M-7.9% | ||
| $6.82M+35.0% | $6M+18.8% | $5.33M+5.4% | $5.05M0.0% | $5.05M0.0% | ||
| $186.73M— | $251.99M— | —— | —— | —— | ||
| $11.5M+83.8% | $10.45M+75.3% | $8.3M+39.4% | $7.3M+21.9% | $6.26M+6.6% | ||
| $23.9M— | $53.43M— | —— | —— | —— | ||
| $9.53M— | $9.65M— | $4.11M— | $3.55M— | —— | ||
| —— | —— | —— | —— | $0— | ||
| $3.05M+13.3% | $2.96M+13.4% | $2.87M— | $2.78M— | $2.7M— | ||
| $2.71M0.0% | $2.71M0.0% | $2.71M0.0% | $2.71M0.0% | $2.71M0.0% | ||
| $4.91M+41.5% | $4.14M+65.7% | $4.28M+83.9% | $3.79M+75.9% | $3.47M+60.6% | ||
| -$921.64M-16.8% | -$967.58M-37.1% | -$906.14M-42.5% | -$868.57M-47.1% | -$789.25M-34.1% | ||
| -$921.64M-16.8% | -$967.58M-37.1% | -$906.14M-42.5% | -$868.57M-47.1% | -$789.25M-34.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insmed generate?
- Insmed (INSM) generated -$895.7M in operating cash flow over the trailing twelve months.
- What is Insmed's free cash flow?
- After $26.0M of capital expenditures, Insmed's free cash flow was -$921.6M over the trailing twelve months, down 16.8% year over year.
- Where does Insmed's cash flow data come from?
- Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
